Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other financing activities (2018 - 2020)

Standard Biotools (LAB) has disclosed Other financing activities for 3 consecutive years, with $18000.0 as the latest value for Q2 2020.

  • Quarterly Other financing activities rose 20.0% to $18000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $375000.0 through Jun 2021, down 25.45% year-over-year, with the annual reading at $12.5 million for FY2022, N/A changed from the prior year.
  • Other financing activities for Q2 2020 was $18000.0 at Standard Biotools, down from $357000.0 in the prior quarter.
  • The five-year high for Other financing activities was $2.6 million in Q2 2018, with the low at $15000.0 in Q2 2019.
  • Average Other financing activities over 3 years is $420625.0, with a median of $98000.0 recorded in 2018.
  • The sharpest move saw Other financing activities plummeted 99.41% in 2019, then increased 20.0% in 2020.
  • Over 3 years, Other financing activities stood at $83000.0 in 2018, then soared by 36.14% to $113000.0 in 2019, then crashed by 84.07% to $18000.0 in 2020.
  • According to Business Quant data, Other financing activities over the past three periods came in at $18000.0, $357000.0, and $113000.0 for Q2 2020, Q1 2020, and Q3 2019 respectively.